Get an overview of how to apply treatment goals to improve your patients' adherence and increase the proportion who reach recovery.
Watch this Webcast to learn how screening tools and neuroimaging can help you assess patients with suspected Alzheimer’s disease.
Find out how DSM criteria and rating scales can help you diagnose ADHD and screen for common comorbid conditions, and learn ways to reduce nonmedical use of your patients' prescriptions.
New! This Commentary summarizes an online CME program on the treatment of depression and assesses outcomes of that program.
Learn about current treatments for insomnia, new research into understanding the sleep-wake cycle, and how that research might play out in treatments.
Read this journal CME study to discover associations between PTSD and cognitive function so that you can help patients minimize modifiable risk factors.
Preventing Domestic Violence in Families of Veterans
Read highlights from a discussion among experts regarding best practices for preventing and identifying violence in the families of veterans.
Review the use of opioid therapy for chronic pain and discover tools that can help you assess patients for abuse risk and safeguard them during treatment.
View 7 of the best research posters from the annual NCDEU meeting, featuring original unpublished studies on tardive dyskinesia during paliperidone treatment, amitifadine and decreased alcohol intake, optimal treatment strategies for major depression, and more.
Residual Symptoms and the Risk of Relapse in Major Depression
Find out how residual symptoms increase your patients' risk for relapse and how to apply treatment options to help them achieve asymptomatic remission.
Discover ways to apply study results to calculate the risk/benefit ratio of agents and determine the best treatment plan for your patients with bipolar depression.
Learn how glutamatergic agents are being used to alleviate negative symptoms by affecting the glycine modulatory site.
Managing Depression to Achieve Remission
Do you treat your patients with MDD until they are asymptomatic? Read this CME Supplement to find out how to recognize, monitor, and treat residual symptoms.
Addressing Barriers to LAIs and Managing Adverse Effects
See how study design affects the results of LAI efficacy in schizophrenia, how to overcome barriers to using LAI treatment, and how to monitor common side effects associated with antipsychotics.
Please take our online poll
Depression in Primary Care
Should PCPs screen everyone for major depression? Some argue that this leads to false positives. What do you think?